# | Title | Journal | Year | Citations |
---|
1 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report | Biology of Blood and Marrow Transplantation | 2005 | 3,213 |
2 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report | Biology of Blood and Marrow Transplantation | 2015 | 2,636 |
3 | ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells | Biology of Blood and Marrow Transplantation | 2019 | 1,741 |
4 | HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide | Biology of Blood and Marrow Transplantation | 2008 | 1,525 |
5 | Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective | Biology of Blood and Marrow Transplantation | 2009 | 1,505 |
6 | Defining the Intensity of Conditioning Regimens: Working Definitions | Biology of Blood and Marrow Transplantation | 2009 | 1,419 |
7 | Chronic graft-versus-host disease | Biology of Blood and Marrow Transplantation | 2003 | 801 |
8 | Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients | Biology of Blood and Marrow Transplantation | 2005 | 745 |
9 | Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2015 | 619 |
10 | Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome | Biology of Blood and Marrow Transplantation | 2010 | 509 |
11 | First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2012 | 506 |
12 | International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium | Biology of Blood and Marrow Transplantation | 2016 | 487 |
13 | Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans | Biology of Blood and Marrow Transplantation | 2010 | 466 |
14 | Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report | Biology of Blood and Marrow Transplantation | 2006 | 445 |
15 | Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2014 | 444 |
16 | Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2005 | 429 |
17 | Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report | Biology of Blood and Marrow Transplantation | 2006 | 427 |
18 | Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide | Biology of Blood and Marrow Transplantation | 2002 | 413 |
19 | Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | 2005 | 406 |
20 | Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies | Biology of Blood and Marrow Transplantation | 2003 | 396 |
21 | Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2009 | 389 |
22 | Current Use of and Trends in Hematopoietic Cell Transplantation in the United States | Biology of Blood and Marrow Transplantation | 2020 | 378 |
23 | Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems | Biology of Blood and Marrow Transplantation | 2002 | 367 |
24 | Transplantation of ex vivo expanded cord blood | Biology of Blood and Marrow Transplantation | 2002 | 356 |
25 | Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markers | Biology of Blood and Marrow Transplantation | 2001 | 354 |
26 | Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2015 | 342 |
27 | Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research | Biology of Blood and Marrow Transplantation | 2015 | 331 |
28 | The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2017 | 328 |
29 | Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation | Biology of Blood and Marrow Transplantation | 2006 | 326 |
30 | Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation | Biology of Blood and Marrow Transplantation | 2012 | 324 |
31 | Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning | Biology of Blood and Marrow Transplantation | 2013 | 324 |
32 | Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation | Biology of Blood and Marrow Transplantation | 2008 | 319 |
33 | Pathophysiologic mechanisms of acute graft-vs.-host disease | Biology of Blood and Marrow Transplantation | 1999 | 317 |
34 | Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report | Biology of Blood and Marrow Transplantation | 2006 | 316 |
35 | Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease | Biology of Blood and Marrow Transplantation | 2011 | 311 |
36 | Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations | Biology of Blood and Marrow Transplantation | 2014 | 305 |
37 | Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice | Biology of Blood and Marrow Transplantation | 2008 | 297 |
38 | Double Unrelated Reduced-Intensity Umbilical Cord Blood Transplantation in Adults | Biology of Blood and Marrow Transplantation | 2007 | 294 |
39 | Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report | Biology of Blood and Marrow Transplantation | 2015 | 293 |
40 | Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia | Biology of Blood and Marrow Transplantation | 2001 | 291 |
41 | Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study | Biology of Blood and Marrow Transplantation | 2011 | 287 |
42 | Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy | Biology of Blood and Marrow Transplantation | 2012 | 282 |
43 | Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2009 | 278 |
44 | Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes | Biology of Blood and Marrow Transplantation | 2002 | 270 |
45 | Searching for unrelated donor hematopoietic stem cells: Availability and speed of umbilical cord blood versus bone marrow | Biology of Blood and Marrow Transplantation | 2002 | 262 |
46 | Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome | Biology of Blood and Marrow Transplantation | 2010 | 260 |
47 | Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts | Biology of Blood and Marrow Transplantation | 2014 | 259 |
48 | Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study | Biology of Blood and Marrow Transplantation | 2015 | 256 |
49 | Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia | Biology of Blood and Marrow Transplantation | 2003 | 253 |
50 | Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes | Biology of Blood and Marrow Transplantation | 2003 | 253 |